Philip Low Insider Profile
11 Followers
Philip Low, Director at IRulya Therapeutics, holds 519.28K shares in IRulya Therapeutics (Ticker: IRLA), holds 0.00 shares in Endocyte (Ticker: ECYT).
Philip Low's Trading History
| IRLAIRulya Therapeutics | May 23, 2022 | Director | Uninformative Buy | ― | $16.10M | |
| ECYTEndocyte | Dec 21, 2018 | ― | Uninformative Sell | 11.58M | $0.00 |
You May Also Like
Philip Low insider profile FAQ
What is the percentage of profitable transactions made by Philip Low?
The percentage of profitable transactions made by Philip Low is 17%.
What is the average return per transaction made by Philip Low?
The average return per transaction made by Philip Low is 29.90%.
What stocks does Philip Low hold?
Philip Low holds: IRLA, ECYT stocks.
What was Philip Low's most profitable transaction?
Philip Low’s most profitable transaction was an Informative Buy of ECYT stock on November 14, 2017. The return on the trade was 395.30%.
What is Philip Low's role in IRulya Therapeutics?
Philip Low's role in IRulya Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
